• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

Black Canyon Bio

Tuesday, June 04, 2024
Start-Up Stadium Session
Oncology
"Black Canyon Bio (BCB) is developing novel products for treating cancer using our proprietary Specific Neo-Antigen Peptides (SNAPTM) Technology platform. SNAPTM Technology has product development applications across many cancers and other diseases. SNAPTM Technology was developed by Dr. Sunil Sharma and his team at the Translational Genomics Research Institute (TGen), part of the City of Hope Medical Network. BCB’s first two products, SNAPTM-Vac (a personalized cancer vaccine) and SNAPTM-TIL (a personalized cellular therapy), will start human clinical testing in 2024. The market for cancer vaccines and cellular therapies is expected to grow exponentially during the next decade."
Company Website: http://www.blackcanyonbio.com

Company HQ City

Phoenix

Company HQ State

AZ

Company HQ Country

United States

CEO/Top Company Official

Ken Carter
Speakers
Ken Carter
Back to Session List

white squarewhite

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS